BEAM
Price
$20.30
Change
+$1.12 (+5.84%)
Updated
Jul 8 closing price
Capitalization
1.93B
34 days until earnings call
FDMT
Price
$4.21
Change
+$0.26 (+6.58%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
195.49M
29 days until earnings call
Interact to see
Advertisement

BEAM vs FDMT

Header iconBEAM vs FDMT Comparison
Open Charts BEAM vs FDMTBanner chart's image
Beam Therapeutics
Price$20.30
Change+$1.12 (+5.84%)
Volume$3.09M
Capitalization1.93B
4D Molecular Therapeutics
Price$4.21
Change+$0.26 (+6.58%)
Volume$30.91K
Capitalization195.49M
BEAM vs FDMT Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. FDMT commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and FDMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (BEAM: $20.30 vs. FDMT: $4.22)
Brand notoriety: BEAM and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 156% vs. FDMT: 60%
Market capitalization -- BEAM: $1.93B vs. FDMT: $195.49M
BEAM [@Biotechnology] is valued at $1.93B. FDMT’s [@Biotechnology] market capitalization is $195.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while FDMT’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • FDMT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FDMT.

Price Growth

BEAM (@Biotechnology) experienced а +15.80% price change this week, while FDMT (@Biotechnology) price change was +1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

FDMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.93B) has a higher market cap than FDMT($195M). BEAM YTD gains are higher at: -18.145 vs. FDMT (-24.237). FDMT has higher annual earnings (EBITDA): -196.46M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. FDMT (321M). FDMT has less debt than BEAM: FDMT (23.9M) vs BEAM (158M). BEAM has higher revenues than FDMT: BEAM (63.6M) vs FDMT (23K).
BEAMFDMTBEAM / FDMT
Capitalization1.93B195M989%
EBITDA-399.03M-196.46M203%
Gain YTD-18.145-24.23775%
P/E RatioN/AN/A-
Revenue63.6M23K276,522%
Total Cash1.22B321M380%
Total Debt158M23.9M661%
TECHNICAL ANALYSIS
Technical Analysis
BEAMFDMT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USGLX66.45N/A
N/A
JHancock U.S. Global Leaders Growth A
IARCX16.72N/A
N/A
Invesco Real Estate C
ADKSX31.46N/A
N/A
Adirondack Small Cap
SMSAX9.91N/A
N/A
SEI Multi Strategy Alternatives F (SIMT)
JDEUX45.89-0.02
-0.04%
JPMorgan US Research Enhanced Equity R6

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with IDYA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+6.84%
IDYA - FDMT
44%
Loosely correlated
+1.37%
IMNM - FDMT
44%
Loosely correlated
-1.61%
BEAM - FDMT
43%
Loosely correlated
+5.84%
RGNX - FDMT
43%
Loosely correlated
+3.68%
CRSP - FDMT
42%
Loosely correlated
+7.09%
More